{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:39Z","timestamp":1792785039010,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100020884","name":"ANID","doi-asserted-by":"crossref","award":["Fondecyt Iniciaci\u00f3n N\u00b011250099"],"award-info":[{"award-number":["Fondecyt Iniciaci\u00f3n N\u00b011250099"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"crossref"}]},{"name":"IADR Latinoamerican Region"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36193-y","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T09:04:47Z","timestamp":1768381487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Image segmentation-based analysis reveals correlation between IL-1RA overexpression and worse survival outcomes in oral squamous cell carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Felipe","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Mart\u00ednez-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfredo Alejandro","family":"Gonz\u00e1lez-Arriagada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoela Domingues","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith David","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven Eric","family":"Niklander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronell","family":"Bologna-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"2","key":"36193_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/0022034519894963","volume":"99","author":"M Du","year":"2020","unstructured":"Du, M., Nair, R., Jamieson, L., Liu, Z. & Bi, P. Incidence trends of Lip, oral Cavity, and pharyngeal cancers: global burden of disease 1990\u20132017. J. Dent. Res. 99 (2), 143\u2013151 (2020).","journal-title":"J. Dent. Res."},{"issue":"3","key":"36193_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"36193_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/froh.2020.00003","volume":"1","author":"RD Coletta","year":"2020","unstructured":"Coletta, R. D., Yeudall, W. A. & Salo, T. Grand challenges in oral cancers. Front. Oral Health. 1, 3 (2020).","journal-title":"Front. Oral Health"},{"issue":"6","key":"36193_CR4","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140 (6), 883\u2013899 (2010).","journal-title":"Cell"},{"issue":"2","key":"36193_CR5","doi-asserted-by":"publisher","first-page":"e1003470","DOI":"10.1371\/journal.pcbi.1003470","volume":"10","author":"SE Acuner Ozbabacan","year":"2014","unstructured":"Acuner Ozbabacan, S. E., Gursoy, A., Nussinov, R. & Keskin, O. The structural pathway of Interleukin 1 (IL-1) initiated signaling reveals mechanisms of oncogenic mutations and SNPs in inflammation and cancer. PLoS Comput. Biol. 10 (2), e1003470 (2014).","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"36193_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12 (1), 31\u201346 (2022).","journal-title":"Cancer Discov"},{"issue":"2","key":"36193_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10555-010-9223-6","volume":"29","author":"DG DeNardo","year":"2010","unstructured":"DeNardo, D. G., Andreu, P. & Coussens, L. M. Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev. 29 (2), 309\u2013316 (2010).","journal-title":"Cancer Metastasis Rev."},{"key":"36193_CR8","doi-asserted-by":"publisher","first-page":"642238","DOI":"10.3389\/froh.2021.642238","volume":"2","author":"SE Niklander","year":"2021","unstructured":"Niklander, S. E. Inflammatory mediators in oral cancer: pathogenic mechanisms and diagnostic potential. Front. Oral Health. 2, 642238 (2021).","journal-title":"Front. Oral Health"},{"issue":"35","key":"36193_CR9","doi-asserted-by":"publisher","first-page":"37398","DOI":"10.18632\/oncotarget.6054","volume":"6","author":"X Le\u00f3n","year":"2015","unstructured":"Le\u00f3n, X. et al. Expression of IL-1\u03b1 correlates with distant metastasis in patients with head and neck squamous cell carcinoma. Oncotarget 6 (35), 37398\u201337409 (2015).","journal-title":"Oncotarget"},{"issue":"49","key":"36193_CR10","doi-asserted-by":"publisher","first-page":"29047","DOI":"10.18632\/oncotarget.25540","volume":"9","author":"C Goertzen","year":"2018","unstructured":"Goertzen, C. et al. Oral inflammation promotes oral squamous cell carcinoma invasion. Oncotarget 9 (49), 29047\u201329063 (2018).","journal-title":"Oncotarget"},{"key":"36193_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-94-024-0921-5_2","volume":"941","author":"AS Yazdi","year":"2016","unstructured":"Yazdi, A. S. & Ghoreschi, K. The Interleukin-1 family. Adv. Exp. Med. Biol. 941, 21\u201329 (2016).","journal-title":"Adv. Exp. Med. Biol."},{"issue":"9","key":"36193_CR12","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1073\/pnas.88.9.3681","volume":"88","author":"S Haskill","year":"1991","unstructured":"Haskill, S. et al. cDNA cloning of an intracellular form of the human Interleukin 1 receptor antagonist associated with epithelium. Proc. Natl. Acad. Sci. U S A. 88 (9), 3681\u20133685 (1991).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"36193_CR13","doi-asserted-by":"publisher","first-page":"722676","DOI":"10.3389\/froh.2021.722676","volume":"2","author":"SE Niklander","year":"2021","unstructured":"Niklander, S. E., Murdoch, C. & Hunter, K. D. IL-1\/IL-1R signaling in head and neck cancer. Front. Oral Health. 2, 722676 (2021).","journal-title":"Front. Oral Health"},{"issue":"6256","key":"36193_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/343341a0","volume":"343","author":"SP Eisenberg","year":"1990","unstructured":"Eisenberg, S. P. et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343 (6256), 341\u2013346 (1990).","journal-title":"Nature"},{"issue":"11","key":"36193_CR15","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1007\/s11095-013-1118-0","volume":"30","author":"MS Akash","year":"2013","unstructured":"Akash, M. S., Rehman, K. & Chen, S. IL-1Ra and its delivery strategies: inserting the association in perspective. Pharm. Res. 30 (11), 2951\u20132966 (2013).","journal-title":"Pharm. Res."},{"issue":"4","key":"36193_CR16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/jcp.24816","volume":"230","author":"CH Lee","year":"2015","unstructured":"Lee, C. H. et al. IL-1\u03b2 promotes malignant transformation and tumor aggressiveness in oral cancer. J. Cell. Physiol. 230 (4), 875\u2013884 (2015).","journal-title":"J. Cell. Physiol."},{"key":"36193_CR17","doi-asserted-by":"publisher","first-page":"20208","DOI":"10.1038\/srep20208","volume":"6","author":"T Wu","year":"2016","unstructured":"Wu, T. et al. Modulation of IL-1\u03b2 reprogrammes the tumor microenvironment to interrupt oral carcinogenesis. Sci. Rep. 6, 20208 (2016).","journal-title":"Sci. Rep."},{"key":"36193_CR18","doi-asserted-by":"crossref","unstructured":"Niklander, S. E., Crane, H. L., Darda, L., Lambert, D. W. & Hunter, K. D. The role of icIL-1RA in keratinocyte senescence and development of the senescence-associated secretory phenotype. J. Cell. Sci. 134 (4), 1\u201316 (2021).","DOI":"10.1242\/jcs.252080"},{"issue":"5","key":"36193_CR19","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.3892\/ijo.2015.2917","volume":"46","author":"M Shiiba","year":"2015","unstructured":"Shiiba, M. et al. Interleukin-1 receptor antagonist (IL1RN) is associated with suppression of early carcinogenic events in human oral malignancies. Int. J. Oncol. 46 (5), 1978\u20131984 (2015).","journal-title":"Int. J. Oncol."},{"issue":"6","key":"36193_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3109\/00365529709025103","volume":"32","author":"H Iwagaki","year":"1997","unstructured":"Iwagaki, H., Hizuta, A. & Tanaka, N. Interleukin-1 receptor antagonists and other markers in colorectal cancer patients. Scand. J. Gastroenterol. 32 (6), 577\u2013581 (1997).","journal-title":"Scand. J. Gastroenterol."},{"issue":"2","key":"36193_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0304-3835(99)00162-7","volume":"142","author":"N Iizuka","year":"1999","unstructured":"Iizuka, N. et al. Interleukin-1 receptor antagonist mRNA expression and the progression of gastric carcinoma. Cancer Lett. 142 (2), 179\u2013184 (1999).","journal-title":"Cancer Lett."},{"issue":"1","key":"36193_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0090-8258(02)00154-3","volume":"89","author":"R Fujiwaki","year":"2003","unstructured":"Fujiwaki, R. et al. Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinoma. Gynecol. Oncol. 89 (1), 77\u201383 (2003).","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"36193_CR23","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin, M. B. et al. The eighth edition AJCC cancer staging manual: continuing to build a Bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J. Clin. 67 (2), 93\u201399 (2017).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"36193_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41522-024-00511-x","volume":"10","author":"L Cai","year":"2024","unstructured":"Cai, L. et al. Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma. NPJ Biofilms Microbiomes. 10 (1), 39 (2024).","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"2","key":"36193_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41419-021-03426-z","volume":"12","author":"L Klemke","year":"2021","unstructured":"Klemke, L. et al. Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer. Cell. Death Dis. 12 (2), 155 (2021).","journal-title":"Cell. Death Dis."},{"issue":"3","key":"36193_CR26","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00428-021-03063-z","volume":"479","author":"B Xu","year":"2021","unstructured":"Xu, B. et al. The prognostic role of histologic grade, worst pattern of invasion, and tumor budding in early oral tongue squamous cell carcinoma: a comparative study. Virchows Arch. 479 (3), 597\u2013606 (2021).","journal-title":"Virchows Arch."},{"issue":"6","key":"36193_CR27","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/hed.23380","volume":"36","author":"A Almangush","year":"2014","unstructured":"Almangush, A. et al. Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck. 36 (6), 811\u2013818 (2014).","journal-title":"Head Neck"},{"issue":"15","key":"36193_CR28","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1002\/cncr.24396","volume":"115","author":"C Liebig","year":"2009","unstructured":"Liebig, C., Ayala, G., Wilks, J. A., Berger, D. H. & Albo, D. Perineural invasion in cancer: a review of the literature. Cancer. 115 (15), 3379\u20133391 (2009).","journal-title":"Cancer"},{"issue":"6","key":"36193_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1109\/MSP.2003.1253553","volume":"20","author":"D Sage","year":"2003","unstructured":"Sage, D. & Unser, M. Teaching image-processing programming in Java. IEEE. Signal. Process. Mag. 20 (6), 43\u201352 (2003).","journal-title":"IEEE. Signal. Process. Mag."},{"issue":"1","key":"36193_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/imr.12614","volume":"281","author":"A Mantovani","year":"2018","unstructured":"Mantovani, A., Barajon, I. & Garlanda, C. IL-1 and IL-1 regulatory pathways in cancer progression and therapy. Immunol. Rev. 281 (1), 57\u201361 (2018).","journal-title":"Immunol. Rev."},{"key":"36193_CR31","doi-asserted-by":"crossref","unstructured":"Gelfo, V. et al. Roles of IL-1 in cancer: from tumor progression to resistance to targeted therapies. Int. J. Mol. Sci. 21 (17), 1-14 (2020).","DOI":"10.3390\/ijms21176009"},{"key":"36193_CR32","doi-asserted-by":"publisher","first-page":"100723","DOI":"10.1016\/j.oor.2025.100723","volume":"13","author":"RG K HS","year":"2025","unstructured":"K HS, R. G., Veeraraghavan, V. P. & Ramani, J. S. Pro-inflammatory mediator and cancer-associated chemokine CXCL8 as a prognostic indicator of tumor aggressiveness, angiogenesis, and disease progression with focus on therapeutic implications and recurrence monitoring. Oral Oncol. Rep. 13, 100723 (2025).","journal-title":"Oral Oncol. Rep."},{"issue":"11","key":"36193_CR33","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1158\/2326-6066.CIR-15-0017","volume":"3","author":"JE Glogauer","year":"2015","unstructured":"Glogauer, J. E., Sun, C. X., Bradley, G. & Magalhaes, M. A. Neutrophils increase oral squamous cell carcinoma invasion through an Invadopodia-Dependent pathway. Cancer Immunol. Res. 3 (11), 1218\u20131226 (2015).","journal-title":"Cancer Immunol. Res."},{"key":"36193_CR34","doi-asserted-by":"crossref","unstructured":"Chiu, J. W., Binte Hanafi, Z., Chew, L. C. Y., Mei, Y. & Liu, H. IL-1\u03b1 Processing, signaling and its role in cancer progression. Cells 10 (1), 1-19 (2021).","DOI":"10.3390\/cells10010092"},{"issue":"11","key":"36193_CR35","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1210\/mend-5-11-1740","volume":"5","author":"MK Sgagias","year":"1991","unstructured":"Sgagias, M. K., Kasid, A. & Danforth, D. N. Jr Interleukin-1 alpha and tumor necrosis factor-alpha (TNF alpha) inhibit growth and induce TNF messenger RNA in MCF-7 human breast cancer cells. Mol. Endocrinol. 5 (11), 1740\u20131747 (1991).","journal-title":"Mol. Endocrinol."},{"issue":"6808","key":"36193_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/35040600","volume":"408","author":"Y Xu","year":"2000","unstructured":"Xu, Y. et al. Structural basis for signal transduction by the Toll\/interleukin-1 receptor domains. Nature 408 (6808), 111\u2013115 (2000).","journal-title":"Nature"},{"issue":"18","key":"36193_CR37","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1101\/gad.1455706","volume":"20","author":"K Shchors","year":"2006","unstructured":"Shchors, K. et al. The Myc-dependent angiogenic switch in tumors is mediated by Interleukin 1beta. Genes Dev. 20 (18), 2527\u20132538 (2006).","journal-title":"Genes Dev."},{"issue":"3","key":"36193_CR38","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/path.4173","volume":"230","author":"CH Lee","year":"2013","unstructured":"Lee, C. H. et al. Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma. J. Pathol. 230 (3), 298\u2013309 (2013).","journal-title":"J. Pathol."},{"issue":"1","key":"36193_CR39","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1186\/s12967-023-04343-9","volume":"21","author":"SF Yuan","year":"2023","unstructured":"Yuan, S. F. et al. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR\/JNK\/SOX2 pathway. J. Transl Med. 21 (1), 473 (2023).","journal-title":"J. Transl Med."},{"key":"36193_CR40","doi-asserted-by":"publisher","first-page":"102428","DOI":"10.1016\/j.tranon.2025.102428","volume":"58","author":"Y Ding","year":"2025","unstructured":"Ding, Y., Shan, Y., Gu, J., Yi, J. & Sun, Z. IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type \u2160 interferon response. Transl Oncol. 58, 102428 (2025).","journal-title":"Transl Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36193-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36193-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36193-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T09:20:49Z","timestamp":1770369649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36193-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36193"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36193-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5272"}}